Literature DB >> 12642102

Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin.

Lauren M Brum1, Peter C Turner, Heather Devick, M Teresa Baquero, Richard W Moyer.   

Abstract

The cowpox virus (CPV) glycoprotein serpin SPI-3, a functional protease inhibitor, and the viral hemagglutinin (HA) are required to prevent fusion of wt CPV infected cells. SPI-3 and HA from CPV infected cells co-localize to the plasma membrane and are found in extracellular enveloped virus (EEV). We also show that an N-terminal SPI-3 signal sequence, but not glycosylation, is required for membrane localization and fusion inhibition. In the absence of HA (CPVDeltaHA), no SPI-3 is found on the membrane and infected cells fuse. Conversely, HA from both wt CPV and CPVDeltaSPI-3 infections is on the membrane, indicating a requirement of HA for SPI-3 plasma membrane localization. In the absence of HA, secretion of SPI-3 or SPI-3 N-glyc(-) was markedly enhanced, suggesting HA serves to retain SPI-3 on the plasma membrane,thereby preventing cell fusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642102     DOI: 10.1016/s0042-6822(02)00017-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.

Authors:  Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

2.  Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.

Authors:  Parag Parekh; Zhiwen Tang; Peter C Turner; Richard W Moyer; Weihong Tan
Journal:  Anal Chem       Date:  2010-10-15       Impact factor: 6.986

3.  Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.

Authors:  Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

Review 4.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

5.  Suppressors of a host range mutation in the rabbitpox virus serpin SPI-1 map to proteins essential for viral DNA replication.

Authors:  Benjamin G Luttge; Richard W Moyer
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Vaccinia Virus Phospholipase Protein F13 Promotes Rapid Entry of Extracellular Virions into Cells.

Authors:  Peter Bryk; Matthew G Brewer; Brian M Ward
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Authors:  Natasha M Girgis; Brian C Dehaven; Xin Fan; Kendra M Viner; Mohammad Shamim; Stuart N Isaacs
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.

Authors:  Timothy R Wagenaar; Suany Ojeda; Bernard Moss
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

9.  The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus.

Authors:  Peter C Turner; Richard W Moyer
Journal:  Virology       Date:  2008-08-28       Impact factor: 3.616

10.  Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.

Authors:  Beatriz Perdiguero; María M Lorenzo; Rafael Blasco
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.